Organogenesis Holdings Inc expected to post a loss of 1 cent a share - Earnings Preview

Organogenesis Holdings

08/11/2024 21:55

* Organogenesis Holdings Inc  ORGO.OQ   ORGO.O  is expected
to show a rise in quarterly revenue when it reports  results on
November 12 for the period ending September 30 2024
    * The Canton Massachusetts-based  company is expected to
report a
0.3% increase in revenue to $108.833 million from $108.53
million a year ago, according to the mean estimate from 3
analysts, based on LSEG data.The company's guidance on August 8
2024, for the period ended September 30, was for revenue between
$105.00 million and $113.00 million.
    * ​LSEG's mean analyst estimate for Organogenesis Holdings
Inc is
for a loss of 1 cent per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "Buy".​
    * Wall Street's median 12-month price target for
Organogenesis
Holdings Inc is $4.25​, above​ its last closing price of $3.26.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  0.00        0.00       0.04      Beat    
 Mar. 31 2024  -0.03       -0.03      -0.02     Beat    25
 Dec. 31 2023  0.01        0.01       0.00      Missed  -100​
 Sep. 30 2023  0.00        0.01       0.02      Beat    300
 ​​Jun.        0.02        0.03       0.04      Beat    60
 30 2023                                                
 Mar. 31 2023  -0.02       -0.02      -0.02     Met     0​
 Dec. 31 2022  0.05        0.05       0.06      Beat    20
 Sep. 30 2022  0.06        0.06       0.00      Missed  -100
 This summary was machine generated November 8 at 21:55 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)